Prevention of pathological change and cognitive degeneration of Tg2576 mice by inoculating Aβ1-15 vaccine

Science in China, Series C: Life Sciences

Volumn 51, Issue 8, 2008, Pages 743-750

  Hu, JinJia ^a   Li, GuoYing ^b   Wang, HuaQiao ^c   Lin, Xian ^c   Yao, ZhiBin ^c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

amyloid peptide; Alzheimer's disease; Senile plaque; Tg2576 mice; Vaccine

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 15); AMYLOID BETA-PROTEIN (1-15); PEPTIDE FRAGMENT; VACCINE;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL; ARTICLE; BRAIN; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; HUMAN; IMMUNOLOGY; KIDNEY; LIVER; LUNG; MAZE TEST; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOIDOSIS; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY; LIVER; LUNG; MAZE LEARNING; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; RANDOM ALLOCATION; VACCINES;

MUS;

EID: 48749122184     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-008-0094-9     Document Type: Article

References (19)

1. J. C. Dohart K. Bales K. S. Gannon 2002 Immunizarion reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model Nat Neurosci 5 452 457
2. G. W. Arendash M. N. Gordon D. M. Diamond 2001 Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: Task specificity and correlations between Abeta deposition and spatial memory DNA Cell Biol 20 737 744
3. D. Schenk 2002 Amyloid-beta immunotherapy for Alzheimer's disease: The end of the beginning Nat Rev Neurosci 3 824 828
4. A. R. Jams Nicoll W. David 2003 Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: A case report Nat Med 10 1 5
5. 1-42 J Neuroimmunology 132 49 59
6. 42 J Anatomy (in Chinese) 34 231 235
7. 42 vaccine effectively induced rats to produce specific antibody J Sun-Yatsen Univ (Med Sci) (in Chinese) 25 39 44
8. 42 and its subunit vaccines J Cell Mol Immun (in Chinese) 20 178 180
9. R. Morris 2000 A Preliminary study on the memory attribution and methodology in morris water maze test J Guangzhou Univ Tradit Chin Med 17 117 187
10. D. Schenk R. Barbour W. Dunn 1999 Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 173 177
11. C. Janus J. Mclaurin P. M. Mathews 2000 Aβ peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease Nature 408 979 982
12. D. Morgan D. M. Diamond P. E. Gottschall 2000 Aβ-peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408 982 985
13. R. Prelli E. Castano G. G. Glenner 1988 Differences between vascular and plaque core amyloid in Alzheimer's disease J Neurochem 51 648 651
14. M. Greer J. Murphy S. Lysea 1994 Development of a monoclonal antibody specific for the COOH-terminal of β-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders Am J Pathol 144 1082 1088
15. D. S. Wang R. B. Lipton M. J. Katz 2005 Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging J Neuropathol Exp Neurol 64 378 385
16. Z. Hong J. T. Zhang 2001 Neuroglial and its roles in pathogendsis of the Alzheimer's disease Chin Pharm J 36 212 220
17. D. Frenkel O. Katz B. Solomon 2000 Immunization against Alzheimer's beta amyloid plaque via EFRH phage administration Proc Natl Acad Sci USA 97 11455 11459
18. A. Monsonogo R. Maron V. Zoto 2001 Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mices implications for the pathogenesis and treatment of Alzheimer's disease Proc matl Acad Sci USA 98 10273 10278
19. R.K. Gupta G.R. Siber 1995 Adjuvants for human vaccines-Current status, problems and future prospects Vaccine 13 1263 1276